Utility of a next generation framework for assessment of genomic damage: a case study using the pharmaceutical drug candidate etoposide.

Nicolette, JLuijten, MSasaki, JCCuster, LEmbry, MFroetsch, RJohnson, lGal., et2025-03-272025-03-2720213477564510.1002/em.22467https://rivm.openrepository.com/handle/10029/653639Utility of a next generation framework for assessment of genomic damage: a case study using the pharmaceutical drug candidate etoposide.ArticleEnviron Mol Mutagen 2021 ; 62(9):512-252025-03-27